Evaluation of hepatitis B virus promoters for sustained transgene expression in mice by bioluminescence imaging

Virus Research
Fang ZhaoLin-sheng Zhan

Abstract

To find new liver-specific expression cassettes for long-term expression of therapeutic genes in the context of pDNA, the function and specificity of hepatitis B virus (HBV)' two hepatic enhancers (EnI and EnII), combined with HBV core and X promoters in cultured cells were evaluated. By bioluminescence imaging and hydrodynamic gene transfer technology, the persistence of transgene expression containing these regulatory sequences in the liver of mice was assessed. Our data indicated that both HBV enhancers were able to stimulate HBV core and X promoter activity in cultured cells of hepatic origin. In vivo, HBV core promoter linked to EnI and EnII (EII-EI-Pc) and X promoter linked to EnI and EnII (EI-EII-Px) could direct a constant and high-level gene expression.

References

Jul 1, 1990·Molecular and Cellular Biology·R DiksteinY Shaul
Mar 1, 1996·Biological Chemistry Hoppe-Seyler·P LöserM Strauss
Apr 2, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·M Gabriela KramerJesus Prieto
Jan 30, 2004·Molecular and Cellular Biology·Gilad Doitsh, Yosef Shaul
Sep 8, 2004·The Journal of Gene Medicine·Kathryn L NashAndrew M L Lever

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.